Tango Therapeutics (TNGX) Revenue (2020 - 2025)

Tango Therapeutics' Revenue history runs 6 years deep, the most recent figure standing at $53.8 million for Q3 2025.

• In Q3 2025, Revenue rose 363.61% year-over-year to $53.8 million; the TTM figure through Mar 2026 stood at $57.0 million (up 39.04% YoY), while the FY2025 annual figure was $62.4 million, up 48.29% from the prior year.
• Revenue was $53.8 million for Q3 2025 at Tango Therapeutics, up from $3.2 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $53.8 million in Q3 2025 to a low of $3.2 million in Q2 2025.
• Historically, Revenue has averaged $10.7 million across 5 years, with a median of $6.4 million in 2022.
• Biggest YoY gain for Revenue was 363.61% in 2025; the steepest drop was 83.99% in 2025.
• A 5-year view of Revenue shows it stood at $5.7 million in 2021, then rose by 12.16% to $6.4 million in 2022, then declined by 15.29% to $5.4 million in 2023, then decreased by 24.19% to $4.1 million in 2024, then soared by 1207.04% to $53.8 million in 2025.
• The last three Revenue figures came in at $53.8 million (Q3 2025), $3.2 million (Q2 2025), and $5.4 million (Q1 2025), per Business Quant data.